{
  "title": "Orphan Drugs Market Size & Share Analysis - Growth Trends and Forecast (2025 - 2031)",
  "slug": "orphan-drugs-market",
  "industry": "Pharmaceuticals & Therapeutics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/orphan-drugs-market",
  "scraped_at": "2026-09-17T17:43:43+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 245.6,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 334.28,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 6.36,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "What is the projected value of the orphan drugs market in 2031?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "It is expected to reach USD 334.28 billion, expanding at a 6.36% CAGR between 2026 and 2031."
      }
    },
    {
      "@type": "Question",
      "name": "Why are biologics growing faster than small molecules in rare diseases?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Gene therapies, monoclonal antibodies, and cell-based platforms are displacing older small-molecule treatments and drive a 10.85% CAGR for biologics."
      }
    },
    {
      "@type": "Question",
      "name": "Which region is forecast to grow the fastest through 2031?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific is forecast to post the strongest 11.62% CAGR between 2025 and 2030."
      }
    },
    {
      "@type": "Question",
      "name": "How are online pharmacies influencing distribution?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Online specialty pharmacies are growing at a 13.12% CAGR by combining cold-chain delivery with remote nursing support."
      }
    },
    {
      "@type": "Question",
      "name": "What policy shift will affect U.S. orphan-drug pricing after 2026?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The Inflation Reduction Act narrows the orphan exemption, so sponsors stagger indications to delay Medicare negotiations."
      }
    },
    {
      "@type": "Question",
      "name": "Which disease area is expected to post the highest growth rate?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Neurologic disorders, fueled by gene therapies and Alzheimer's antibodies, are set to grow at 12.75% CAGR through 2031."
      }
    }
  ],
  "images": [
    "images/orphan-drugs-market-size-image-1776018996600.png",
    "images/orphan-drugs-market-1770810424302-major-players.png",
    "images/orphan-drugs-market-Orphan-Drugs-Market-Market-Share-by-Drug-Type-2025-1770809745638.png",
    "images/orphan-drugs-market-Orphan-Drugs-Market-Market-Share-by-Distribution-Channel-2025-1770816438126.png",
    "images/orphan-drugs-market-Orphan-Drugs-Market-CAGR--Growth-Rate-by-Region-2026---2031-1770810051787.png",
    "images/orphan-drugs-market-competitive-landscape-1770812549239.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/orphan-drugs-market-size-image-1776018996600.png"
  ],
  "sections_count": 13
}